Evaluation of a multiple breath nitrogen washout system in children

Abstract
Introduction The multiple breath nitrogen washout (MBW) test offers a sensitive measure of airway function. In this study we aim to (a) assess the validity of the EasyOne Pro LAB (MBWndd) in an in vitro lung model, (b) assess the feasibility, repeatability, and reproducibility of MBWndd and (c) compare outcomes with the Exhalyzer D (MBWEM) and body plethysmography. Methods In vitro, functional residual capacity (FRC) measurements were assessed using a lung model under quasi-physiological conditions and compared to measured FRC. In vivo plethysmography and MBW were performed in a prospective study of children at two visits (n = 45 healthy; n = 41 cystic fibrosis [CF]). Bland-Altman plots were used to compare agreement between FRC and lung clearance index (LCI) measurements. Results In vitro FRCndd measurements were repeatable but lung volumes were underestimated (mean relative difference −5.4% (limits of agreement [LA] −9.6%; −1.1%), 95% confidence interval (CI) −6.27; −4.45). In vivo, compared to plethysmography, FRCndd was consistently lower (−19.3% [−40.5; 1.9], 95% CI [−23.9; −14.7]), and showed a volume dependency. LCIndd values were also higher in children with smaller lung volumes. The within-test coefficient of variation of the FRCndd and LCIndd were 4.9% in health, and 5.6% and 6.9% in CF respectively. LCIndd was reproducible between-visits (mean relative difference [LA] −3.7% [−14.8, −7.5; 95% CI −6.6; −0.73] in health [n = 17] and 0.34% [−13.2, 22.8; 95% CI −5.0; 5.69] in CF [n = 23]). When calculated using the same algorithm, LCIndd was similar to LCIEM in health. Conclusions MBWndd measurements are feasible, repeatable, and reproducible, however, MBW-derived outcomes are not interchangeable with MBWEM.
Funding Information
  • Vertex Pharmaceuticals